Newsletter #1 – When AI Enters the Core
In May 2025, Johnson & Johnson announced a significant shift in its AI strategy. After supporting nearly 900 generative AI projects, the company found that only 10–15% delivered 80% of the value. Consequently, J&J moved from centralized governance to empowering individual business units to manage AI initiatives, focusing on high-impact areas like drug discovery and […]
